BioLife Solutions, Inc. (BLFS)
USD 24.98
(-7.03%)
USD 24.98
(-7.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.49 Million | -8.48 Million | -4.83 Million | 6.51 Million | 1.21 Million | 2.34 Million |
| Net Income | -66.42 Million | -139.8 Million | -7.63 Million | 2.66 Million | -1.65 Million | 3.26 Million |
| Depreciation & Amortization | 12.29 Million | 16.47 Million | 12.86 Million | 5.06 Million | 1.79 Million | 338 Thousand |
| Deferred income taxes | -62 Thousand | -5.23 Million | -20.12 Million | -3.29 Million | -1.54 Million | 672 Thousand |
| Stock-based compensation | 31.67 Million | 25.33 Million | 13.95 Million | 5.98 Million | 3.04 Million | 1.51 Million |
| Change in working capital | 1.46 Million | -14.9 Million | -3.53 Million | -1.78 Million | -4.47 Million | -3.32 Million |
| Other non-cash items | 8.55 Million | 109.65 Million | -364 Thousand | -2.12 Million | 4.04 Million | -127 Thousand |
| Investing Cash Flow | 17.83 Million | -58.11 Million | -12.64 Million | -23.73 Million | -27.01 Million | -6.5 Million |
| Investments in PPE | -6.38 Million | -10.38 Million | -8.38 Million | -4.63 Million | -675 Thousand | -500 Thousand |
| Acquisitions | 4.85 Million | - | 1.55 Million | -15.94 Million | -22.18 Million | -6 Million |
| Investment purchases | -31.95 Million | -53.11 Million | -6.37 Million | -1 Million | -2.5 Million | -6 Million |
| Sales/Maturities of investments | 56.16 Million | 8.92 Million | 6.37 Million | 1.01 Million | - | - |
| Other Investing Activities | -4.85 Million | -3.53 Million | -5.81 Million | -3.17 Million | -1.65 Million | -6 Million |
| Financing Cash Flow | 10.59 Million | 16.31 Million | -2.77 Million | 101.22 Million | 1.59 Million | 28.14 Million |
| Debt repayment | -498 Thousand | -2.16 Million | -2.89 Million | -2.17 Million | - | -25 Thousand |
| Dividends payments | - | - | - | - | - | -436 Thousand |
| Common Stock Repurchased | - | - | - | - | - | -4.25 Million |
| Common Stock Issuance | 10.75 Million | -131 Thousand | 1.27 Million | 100.12 Million | 1.75 Million | 20 Million |
| Other Financing Activities | 338 Thousand | 18.61 Million | -1.15 Million | 3.27 Million | -159 Thousand | 12.85 Million |
| Accounts receivables | 15.35 Million | -10.75 Million | -10.13 Million | -1.78 Million | -290 Thousand | -2.02 Million |
| Accounts payables | -8.42 Million | 414 Thousand | 2.01 Million | -171 Thousand | 768 Thousand | -11 Thousand |
| Inventory | -8.55 Million | -6.55 Million | 114 Thousand | -629 Thousand | -3.77 Million | -1.66 Million |
| Other working capital | 3.09 Million | 1.99 Million | 4.46 Million | 805 Thousand | -1.17 Million | 377 Thousand |
| Cash at beginning of period | 19.47 Million | 69.87 Million | 90.45 Million | 6.44 Million | 30.65 Million | 6.66 Million |
| Cash at end of period | 35.43 Million | 19.47 Million | 69.87 Million | 90.45 Million | 6.44 Million | 30.65 Million |
| Capital Expenditure | -6.38 Million | -10.38 Million | -8.38 Million | -4.63 Million | -675 Thousand | -500 Thousand |
| Effect of forex changes on cash | 35 Thousand | -108 Thousand | -282 Thousand | - | - | - |
| Net cash flow / Change in cash | 15.96 Million | -50.39 Million | -20.58 Million | 84 Million | -24.2 Million | 23.99 Million |
| Free Cash Flow | -18.87 Million | -18.87 Million | -13.22 Million | 1.88 Million | 538 Thousand | 1.84 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.14 Million | -10.22 Million | -13.38 Million | -66.42 Million | -29.13 Million | -10.19 Million |
| Depreciation & Amortization | 2.41 Million | 2.27 Million | 2.38 Million | 12.29 Million | 3.27 Million | 3.45 Million |
| Deferred income taxes | - | 5000.00 | -98 Thousand | -62 Thousand | 23 Thousand | -8.99 Million |
| Stock-based compensation | 8.71 Million | 6.18 Million | 8.33 Million | 31.67 Million | 9.11 Million | 6.85 Million |
| Change in working capital | 3.23 Million | -2.63 Million | 5.23 Million | 1.46 Million | -1.89 Million | -1.32 Million |
| Other non-cash items | 11.76 Million | 12.5 Million | -160 Thousand | 8.55 Million | 14.23 Million | 2.48 Million |
| Investing Cash Flow | -13.43 Million | -221 Thousand | 3.95 Million | 17.83 Million | 1.66 Million | 9.29 Million |
| Investments in PPE | -995 Thousand | -356 Thousand | -981 Thousand | -6.38 Million | -1.49 Million | -609 Thousand |
| Acquisitions | -14.01 Million | 973 Thousand | -2.97 Million | 4.85 Million | 1.11 Million | 1.32 Million |
| Investment purchases | -5.46 Million | -6.83 Million | -5.81 Million | -31.95 Million | -6.96 Million | -7.52 Million |
| Sales/Maturities of investments | 7.04 Million | 6 Million | 13.71 Million | 56.16 Million | 11.01 Million | 18.97 Million |
| Other Investing Activities | -1.13 Million | -464 Thousand | -1.4 Million | -4.85 Million | -2.02 Million | -2.87 Million |
| Financing Cash Flow | -704 Thousand | -952 Thousand | 9.84 Million | 10.59 Million | 608 Thousand | 704 Thousand |
| Debt repayment | -227 Thousand | -241 Thousand | -801 Thousand | -498 Thousand | -427 Thousand | -129 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 91 Thousand | - | 10.38 Million | 10.75 Million | 64 Thousand | 181 Thousand |
| Other Financing Activities | -568 Thousand | -711 Thousand | 261 Thousand | 338 Thousand | 971 Thousand | 652 Thousand |
| Accounts receivables | -1.93 Million | 65 Thousand | 5.91 Million | 15.35 Million | 2.34 Million | 3.47 Million |
| Accounts payables | 1.19 Million | -1.95 Million | -5.04 Million | -8.42 Million | 1.3 Million | -4.83 Million |
| Inventory | 1.76 Million | 42 Thousand | -102 Thousand | -8.55 Million | -4.17 Million | 2.15 Million |
| Other working capital | 2.23 Million | -790 Thousand | 4.46 Million | 3.09 Million | -1.36 Million | -2.11 Million |
| Cash at beginning of period | 29.72 Million | 35.43 Million | 19.26 Million | 19.47 Million | 21.43 Million | 19.13 Million |
| Cash at end of period | 22.04 Million | 29.72 Million | 35.43 Million | 35.43 Million | 19.26 Million | 2.29 Million |
| Capital Expenditure | -995 Thousand | -356 Thousand | -981 Thousand | -6.38 Million | -1.49 Million | -609 Thousand |
| Effect of forex changes on cash | - | -65 Thousand | 63 Thousand | 35 Thousand | -56 Thousand | 17 Thousand |
| Net cash flow / Change in cash | -7.68 Million | -5.71 Million | 16.17 Million | 15.96 Million | -2.16 Million | -16.84 Million |
| Free Cash Flow | 5.46 Million | -4.83 Million | 1.33 Million | -18.87 Million | -5.87 Million | -8.32 Million |
CELC
IONM
VAIBHAVGBL
PNCINFRA
WINMED
1FC